Showing 1531-1540 of 4173 results for "".
A Case of Pityriasis Lichenoides; Low-Tech/High-Yield Tech Solutions
https://practicaldermatology.com/topics/general-topics/a-case-of-pityriasis-lichenoides-low-techhigh-yield-tech-solutions/20537/Case Report: A 61-year-old man with Pityriasis LichenoidesLet’s Talk About Truncal Acne
https://practicaldermatology.com/topics/acne-rosacea/lets-talk-about-truncal-acne/23785/A look at the burden of truncal acne and current treatment options.The Challenges of Topical Steroid Withdrawal
https://practicaldermatology.com/topics/practice-management/the-challenges-of-topical-steroid-withdrawalogy/21118/Now more widely reported, topical steroid addiction should compel all prescribers to reflect on their use of topical corticosteroids.Electrical Impedance Spectroscopy: Augmented Intelligence Technology for the Early Detection of Melanona
https://practicaldermatology.com/topics/skin-cancer-photoprotection/electrical-impedance-spectroscopy-augmented-intelligence-technology-for-the-early-detection-of-melanona/23262/First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Stirring the Pot: Cannabinoids and Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/stirring-the-pot-cannabinoids-and-atopic-dermatitis/20565/Cannabinoids are a diverse group of compounds that may hold significant therapeutic capabilities applicable to many areas of medicine, including dermatology.Nonsteroidal Topical Therapies for Atopic Dermatitis from Infants to Adults
https://practicaldermatology.com/topics/atopic-dermatitis/nonsteroidal-topical-therapies-for-atopic-dermatitis-from-infants-to-adults/85437/This review covers nonsteroidal topical therapies for atopic dermatitis from infants to adults, including recently FDA-approved options, to help prescribers choose the best option for their patients.GLP-1 Receptor Agonists: Current Roles in Medicine
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-current-roles-in-medicine/48897/In recent years, the popularity of glucagon-like peptide 1 receptor agonists (GLP-1RAs) has skyrocketed, along with interest in clinical applications beyond diabetes and weight management. Here, we present a brief review of GLP-1RAs, including a history, a look at the mechanism of action, pivotal reVitamin D and Psoriasis
https://practicaldermatology.com/topics/practice-management/vitamin-d-and-psoriasis/21470/New findings suggest a relationship between psoriasis and vitamin D deficiency, but larger details are still unknown."Psleep": Psoriasis and Sleep
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/psleep-psoriasis-and-sleep/29075/The “invisible” impacts of psoriasis are those not directly seen on examination. These include itch, pain, fatigue and sleep dysfunction, which may be improved by our systemic therapies. However, there is a gap between the patients’ reporting of these experienced invisible impacts and their physicia